Primer: Anges Mg Inc (4563 JP) - Aug 2026
AnGes is a Japanese biopharmaceutical company focused on the development of gene-based medicines, with a primary focus on gene therapy and...
112 Views
𝛼SK or SearchENTITY
Anges Mg Inc (4563 JP)
Anges Mg Inc (4563 JP)
14
Analysis
Health Care • Japan
AnGes MG, Inc. develops gene-therapy drugs that use Hepatocyte Growth Factor (HGF) for myocardial infarction and arteriosclerosis patients. The Company also develops nucleic acid drug (decoy oligo) for patients with asthma, allergy, and rheumatism. AnGes MG develops vectors (a carrier used to introduce a foreign gene into a host cell) which help study and analyze genetic functions.
morex